In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
4 days 18 hours ago
4 days 22 hours ago
21 weeks 5 days ago
25 weeks 6 days ago
27 weeks 3 days ago
27 weeks 4 days ago
39 weeks 6 days ago
45 weeks 4 days ago
1 year 4 weeks ago
1 year 5 weeks ago